Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Joseena Iype"'
Autor:
Joseena Iype, Lionel Rohner, Sofia Bachmann, Tanja Rahel Hermann, Nikolay Pavlov, Christophe von Garnier, Michaela Fux
Publikováno v:
Frontiers in Immunology, Vol 13 (2023)
BackgroundBasophils in acute asthma exacerbation are activated as evidenced by their increased expression levels of activation markers such as CD203c and CD63. However, whether basophils of allergic asthmatics who are in stable phase and have no asth
Externí odkaz:
https://doaj.org/article/747da077171f4161873cb4306964b16e
Autor:
Joseena Iype, Michaela Fux
Publikováno v:
Cells, Vol 10, Iss 4, p 895 (2021)
Eosinophils are well known to contribute significantly to Th2 immunity, such as allergic inflammations. Although basophils have often not been considered in the pathogenicity of allergic dermatitis and asthma, their role in Th2 immunity has become ap
Externí odkaz:
https://doaj.org/article/38b96716cc7a446381f6c1c6667ba927
Publikováno v:
Scholz, Godehard A; Fux, Michaela; Christ, Lisa; Iype, Joseena; Banz, Yara; Villiger, Peter M (2022). Divergent regulatory T cell responses to high-dose methylprednisolone and tocilizumab in giant cell arteritis. Journal of autoimmunity, 133, p. 102909. Elsevier 10.1016/j.jaut.2022.102909
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fe45da520c811d36fec393081ab37f52
https://boris.unibe.ch/173030/1/1-s2.0-S0896841122001172-main.pdf
https://boris.unibe.ch/173030/1/1-s2.0-S0896841122001172-main.pdf
Publikováno v:
Allergy. 76:2017-2029
Human basophils are essential effector cells of chronic allergic inflammation. IL-1 family cytokines such as interleukin (IL)-33 and IL-1β are elevated in serum and bronchoalveolar lavage fluid of allergic asthmatics. IL-33 is known to be a critical
Autor:
Cornelia Staehelin, Cesare Medri, Robert Hoepner, Susanne Radonjic-Hoesli, Jennifer Amsler, Daniel Aeberli, Michael P. Horn, Matthias B. Moor, Anne Angelillo-Scherrer, Burkhard Moeller, Britta Maurer, Ulrike Bacher, Simeon Schietzel, Cédric Hirzel, S. Morteza Seyed Jafari, Laila-Yasmin Mani, Luca Borradori, Joseena Iype, Michael Nagler, Franziska Suter-Riniker, Daniel Sidler, Alexander Born, Linet M. Njue, Andrew T. Chan
BackgroundMorbidity and mortality of COVID-19 is increased in patients with B-cell depleting therapies, the majority of which also show compromised vaccination-induced immune responses. Herein, we report on the trajectories of anti-SARS-CoV-2 antibod
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9ff8663799b5699f9b72c72ceb1e3725
https://doi.org/10.1101/2021.11.19.21266572
https://doi.org/10.1101/2021.11.19.21266572
Autor:
Cédric Hirzel, Linet M. Njue, Susanne Radonjic-Hoesli, Luca Borradori, Daniel Sidler, Daniel Aeberli, Joseena Iype, Michael P. Horn, Anne Angelillo-Scherrer, Burkhard Möller, Franziska Suter-Riniker, Matthias B. Moor, Britta Maurer, Robert Hoepner, S. Morteza Seyed Jafari, Laila-Yasmin Mani, Jennifer Amsler, Cesare Medri, Vera Ulrike Bacher, Andrew T. Chan
Publikováno v:
The Lancet. Rheumatology
Background B-cell-depleting therapies increase the risk of morbidity and mortality due to COVID-19. Evidence-based SARS-CoV-2 vaccination strategies for patients on B-cell-depleting therapies are scarce. We aimed to investigate humoral and cell-media
Autor:
Cesare Medri, Burkhard Moeller, Morteza Seyed Jafari, Jennifer Amsler, Britta Maurer, Cédric Hirzel, Anne Angelillo-Scherrer, Matthias B. Moor, Michael P. Horn, Daniel Aeberli, Susanne Radonjic-Hoesli, Franziska Suter-Riniker, Robert Hoepner, Linet M. Njue, Laila-Yasmin Mani, Daniel Sidler, Joseena Iype, Andrew T. Chan, Luca Borradori, Vera Ulrike Bacher
BackgroundB-cell depleting therapies increase COVID19 morbidity and mortality. For this specific population, evidence-based vaccination strategies are lacking. Here, we investigated humoral and cell mediated immune responses to SARS-CoV2 mRNA-based v
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8717ba6f640764ecb81dc23940a5de8c
https://doi.org/10.1101/2021.07.04.21259848
https://doi.org/10.1101/2021.07.04.21259848
Publikováno v:
Scientific Reports
Scientific Reports, Vol 10, Iss 1, Pp 1-8 (2020)
Rohner, Lionel; Reinhart, Ramona; Iype, Joseena; Bachmann, Sofia; Kaufmann, Thomas; Fux, Michaela (2020). Impact of BH3-mimetics on Human and Mouse Blood Leukocytes: A Comparative Study. Scientific reports, 10(1), p. 222. Springer Nature 10.1038/s41598-019-57000-x
Scientific Reports, Vol 10, Iss 1, Pp 1-8 (2020)
Rohner, Lionel; Reinhart, Ramona; Iype, Joseena; Bachmann, Sofia; Kaufmann, Thomas; Fux, Michaela (2020). Impact of BH3-mimetics on Human and Mouse Blood Leukocytes: A Comparative Study. Scientific reports, 10(1), p. 222. Springer Nature 10.1038/s41598-019-57000-x
BH3-mimetics are small molecule inhibitors that neutralize the function of anti-apoptotic BCL-2 family members. BH3-mimetics have recently gained a lot of popularity in oncology because of their success in cancer treatment. However, BH3-mimetics migh
Autor:
Annette Schmitt-Graeff, Robert Zeiser, Joseena Iype, Gabriele Prinz, Jürgen Finke, Benjamin A. H. Smith, Alessandro Prestipino, Dietmar Pfeifer, Sophia Chen, Yvonne Beck, Marco Idzko, Justus Duyster, Sebastian Grundmann
Publikováno v:
Blood. 126:103-112
The successful treatment of acute leukemias with allogeneic hematopoietic cell transplantation (allo-HCT) is limited by acute graft-versus-host disease (GVHD). Because microRNA-155 (miR-155) regulates activation of the innate immune system, we aimed
Autor:
Sophia Chen, Joseena Iype, Sebastian Grundmann, Marco Idzko, Annette Schmitt-Gräff, Heide Dierbach, Yvonne Beck, Jürgen Finke, Justus Duyster, Robert Zeiser
Publikováno v:
Blood. 122:3247-3247
Allogeneic hematopoietic cell transplantation (alloHCT) is limited by acute graft-versus-host disease (GvHD) which occurs in 30-40 % of patients. Despite numerous clinical studies, the standard immunosuppressive regimens for prevention of acute GvHD